Completed PHASE2 INTERVENTIONAL 3-arm NCT05279157

Autologous Adipose-Derived Adult Stem Cell Implantation for Corneal Diseases (ADASCs-CT-CD) (ADASCs-CT-CD)

Implantation of Autologous Mesenchymal Stem Cells of Adipose Origin for the Treatment of Corneal Diseases

Sponsor: Instituto de Salud Carlos III

Conditions Corneal Dystrophy Keratoconus Ophthalmological Disorder Therapy Treatment

Interventions Implantation Lipoaspiration

Updated 6 times since 2022 Last updated: May 4, 2023 Started: Apr 19, 2022 Primary completion: Feb 5, 2023 Completion: Feb 5, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Corneal Dystrophy and Keratoconus and is currently completed. Instituto de Salud Carlos III leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jun 2023 — Jul 2024 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Nov 2022 — Jun 2023 [monthly]

Recruiting PHASE2
May 2022 — Nov 2022 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Apr 2022 — May 2022 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto de Salud Carlos III
Universidad Miguel Hernandez de Elche
Vissum, Instituto Oftalmológico de Alicante

Data source: Vissum, Instituto Oftalmológico de Alicante

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Alicante, Spain